Entering text into the input field will update the search result below

Aurinia Pharmaceuticals gains on report investors pushing for sale

The concept of the word M&A on cubes on a beautiful green background

Zhanna Hapanovich/iStock via Getty Images

Aurinia Pharmaceuticals (NASDAQ:AUPH) rose 2.8% on a report that a European-based investor group is campaigning for the biotech to begin a strategic review.

Aurinia holders, led by Switzerland-based MKT Tactical Fund, have written to the AUPH chairman, asking

Recommended For You

About AUPH Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AUPH--
Aurinia Pharmaceuticals Inc.